Restructuring 23andMe: The High-Stakes Balance Between Finance and Data Protection
Complex Discovery
MARCH 24, 2025
Editor’s Note: 23andMes Chapter 11 filing marks a pivotal moment for both the company and the wider biotechnology sector. The objective behind this significant move is to facilitate a sale process that maximizes the value of its business amidst immense financial and operational challenges.
Let's personalize your content